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Purpose/Objective: The use of parotid gland (PG) sparing intensitymodulated radiotherapy (IMRT) significantly reduces high grade xerostomia. Water alone is a poor oral mucosal lubricant; the inorganic and organic salivary components are suggested to increase moisture retention on the mucosa. PG saliva comprises ~70% and 30% of stimulated and unstimulated saliva volume respectively. Despite the use of PG sparing IMRT, rates of high grade xerostomia are ~35% at 1 year. Data on saliva composition analysis post radiotherapy (RT) is limited pre-IMRT due to poor residual salivary flow. We present an analysis of PG saliva flow rate and composition for patients treated with IMRT within four trials at The RMH. Materials and Methods: Samples were collected in the PARSPORT trial (CRUK/003/005) and 3 single institution, phase 2 studies (Midline (CCR 2588), Dose Escalation (CCR1978) and Nasopharynx (CCR 2608)). Stimulated and unstimulated PG salivas were collected from right and left glands using Lashley cups (2% citric acid). Collect was at baseline (BL), 3, 6, 12 and 24 months(m) post-IMRT. Samples were suitable for analysis if a pre-IMRT and chemotherapy (BL) and ≥1 subsequent sample, of adequate volume (>150µl) were collected. Salivas were analysed for protein and ionic components using ELISA (IgA, B2M and lactoferrin), BCA assay (total protein) and ICP-mass spectrometry (Ca 2+ , Na + ). Flow rates were determined gravitometrically (1g=1ml). Samples were statistically analysed for early (3-6m post-IMRT) and late (12-24m post-IMRT) changes using wilcoxon signed rank or paired t-tests and reported as % change from BL. Results: Twenty-one patients provided 120 samples for analysis. Seventeen patients were male, mean patient age was 58.4 yr and 14 received chemotherapy. Mean PG RT dose was 27.8Gy. Sequential results ( 
